Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.

Factors that aid survival of prostate cancer cells in the presence of the various categories of cytotoxic cytokines present in tumors in vivo are largely unknown. Osteoprotegerin (OPG) is a decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) that inhibits TRAIL-induced...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Holen, I, Croucher, P, Hamdy, F, Eaton, C
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2002

Ижил төстэй зүйлс

Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
-н: Eaton, C, зэрэг
Хэвлэсэн: (2004)

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
-н: Eaton, C, зэрэг
Хэвлэсэн: (2004)

OPG is a survival factor for breast- and prostate cancer cells in vitro
-н: Holen, I, зэрэг
Хэвлэсэн: (2002)

Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
-н: Holen, I, зэрэг
Хэвлэсэн: (2002)

Role of osteoprotegerin (OPG) in cancer.
-н: Holen, I, зэрэг
Хэвлэсэн: (2006)

The role of osteoprotegerin in breast and prostate cancer
-н: Holen, I, зэрэг
Хэвлэсэн: (2002)

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
-н: Holen Ingunn, зэрэг
Хэвлэсэн: (2009-07-01)

Myeloma cells can down-regulate release of osteoprotegerin (OPG) from human bone cells - A contributing factor in myeloma bone loss?
-н: Shipman, C, зэрэг
Хэвлэсэн: (2002)

Role of Osteoprotegerin (OPG) in Bone Marrow Adipogenesis
-н: Lili Zhang, зэрэг
Хэвлэсэн: (2016-11-01)

Osteoprotegerin (OPG) is a soluble decoy receptor for TRAIL/Apo2L and can inhibit TRAIL/Apo2L-induced apoptosis of human myeloma cells in vitro.
-н: Shipman, C, зэрэг
Хэвлэсэн: (2002)

Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.
-н: Shipman, C, зэрэг
Хэвлэсэн: (2000)

Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome
-н: Gamal B Mohamed, зэрэг
Хэвлэсэн: (2011-01-01)

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers.
-н: Waterman, E, зэрэг
Хэвлэсэн: (2007)

Polymorphisms within the osteoprotegerin (OPG) gene are associated with both serum OPG levels and bone mineral density.
-н: Miles, L, зэрэг
Хэвлэсэн: (2004)

Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
-н: Croucher, P, зэрэг
Хэвлэсэн: (2000)

Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells
-н: Noura N. Alraouji, зэрэг
Хэвлэсэн: (2024-08-01)

Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
-н: Riham Eid, зэрэг
Хэвлэсэн: (2023-06-01)

Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.
-н: Shipman, C, зэрэг
Хэвлэсэн: (2003)

Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
-н: Siamak Kazemi-Sufi, зэрэг
Хэвлэсэн: (2024-09-01)

Human bone marrow stromal cells protect prostate and breast cancer cells from TRAIL-induced apoptosis
-н: Nyambo, R, зэрэг
Хэвлэсэн: (2004)

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
-н: Nyambo, R, зэрэг
Хэвлэсэн: (2004)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
-н: Chan Kai-Ming, зэрэг
Хэвлэсэн: (2011-07-01)

Osteoprotegerin (OPG): A potential biomarker for adverse cardiovascular events in stable coronary artery disease
-н: Syed Muhammad Muneeb Akhtar, зэрэг
Хэвлэсэн: (2024-07-01)

Osteoprotegerin and the development of myeloma bone disease
-н: Croucher, P, зэрэг
Хэвлэсэн: (2004)

Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
-н: Yao Jing, зэрэг
Хэвлэсэн: (2011-03-01)

Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females
-н: Saba Tariq, зэрэг
Хэвлэсэн: (2022-02-01)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
-н: Yosra Azizpour, зэрэг
Хэвлэсэн: (2020-01-01)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
-н: Yosra Azizpour, зэрэг
Хэвлэсэн: (2020-01-01)

The survival effect of prolactin on PC3 prostate cancer cells.
-н: Ruffion, A, зэрэг
Хэвлэсэн: (2003)

Involvement of FXR in the OPG/RANKL pathway of breast and prostate cancer cells
-н: Lara Absil, зэрэг
Хэвлэсэн: (2021-04-01)

Significant Inverse Correlation of Serum Levels of Osteoprotegerin (OPG) and Transferrin Saturation in Thalassemia Dependent Transfusion (TDT) Patients
-н: Indra Wijaya, зэрэг
Хэвлэсэн: (2024-01-01)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
-н: Croucher, P, зэрэг
Хэвлэсэн: (2003)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
-н: Croucher, P, зэрэг
Хэвлэсэн: (2001)

Determinant Factors and Added Value of Osteoprotegerin (OPG) to Detect Carotid Intima-Media Thickness (CIMT) in Type 2 Diabetes Mellitus Patient
-н: Shirly Elisa Tedjasaputra, зэрэг
Хэвлэсэн: (2018-06-01)

Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids
-н: Salvador Atilano-Miguel, зэрэг
Хэвлэсэн: (2022-01-01)

Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
-н: Lane Denis, зэрэг
Хэвлэсэн: (2012-11-01)

Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
-н: Martin Widschwendter, зэрэг
Хэвлэсэн: (2015-10-01)

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells
-н: Cross, N, зэрэг
Хэвлэсэн: (2008)

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells.
-н: Cross, N, зэрэг
Хэвлэсэн: (2008)

Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.
-н: Vanderkerken, K, зэрэг
Хэвлэсэн: (2003)